Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD4 | P21917 | 12/20 | 0.41 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.41 |
| ▸ | CNR2 | P34972 | 3/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | DRD2 | P14416 | 2/20 | 0.39 |
| ▸ | DRD3 | P35462 | 2/20 | 0.39 |
| ▸ | CYP2A13 | Q16696 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5762970 | 0.87 | DRD4 (0.45) | DRD4SIGMAR1CNR2CYP1A2CYP3A4 | |
| SCHEMBL5762202 | 0.82 | DRD4 (0.46) | DRD4SIGMAR1 | |
| SCHEMBL2920119 | 0.81 | SIGMAR1 (0.41) | DRD4SIGMAR1CNR2CYP1A2CYP3A4 | |
| SCHEMBL5042305 | 0.76 | SLC6A2 (0.59) | DRD4SIGMAR1CNR2CYP1A2CYP3A4 | |
| SCHEMBL14203009 | 0.76 | SLC6A2 (0.59) | DRD4SIGMAR1CNR2CYP1A2CYP3A4 | |
| SCHEMBL8285575 | 0.75 | CNR2 (0.45) | DRD4CNR2CYP1A2CYP3A4CYP2D6 | |
| SCHEMBL25062785 | 0.74 | DRD4 (0.57) | DRD4SIGMAR1CNR2CYP1A2CYP3A4 | |
| SCHEMBL5666570 | 0.73 | DRD4 (0.51) | DRD4SIGMAR1DRD2DRD3 | |
| SCHEMBL5696025 | 0.73 | CNR2 (0.50) | DRD4CNR2CYP1A2CYP3A4CYP2D6 | |
| SCHEMBL14142945 | 0.73 | BCHE (0.43) | DRD4SIGMAR1CNR2CYP1A2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1682523-A1 | MORPHOLINE DERIVATIVES AS NOREPINEPHRINE REUPTAKE INHIBITORS | ELI LILLY AND COMPANY (US) | 2006-07-26 | — | — | EP | disclosed |
| WO-2005047272-A1 | MORPHOLINE DERIVATIVES AS NOREPINEPHRINE REUPTAKE INHIBITORS | ELI LILLY AND COMPANY (US) | 2005-05-26 | — | — | WO | disclosed |